Early results from the Phase 3 PURPOSE 1 trial reveal that an injectable antiretroviral drug, administered twice a year, can effectively prevent HIV infection in cisgender women. Professor Thesla Palanee-Phillips, director of clinical trials at Wits RHI, hailed the...
Seventy percent of foreign-trained doctors who took board exams in October 2023 and February 2024 failed. However, around 250 junior doctors have identified discrepancies in their examination scripts. They are now seeking intervention from the Information Regulator to...
Climate change is causing significant psychological stress and trauma in children, according to a recent report by advocacy organisation Section27. The report highlights the particular vulnerability of children to the extreme weather conditions associated with climate...
Recent data reveals a troubling global trend. People are getting sick more often. Illnesses also appear to be more severe. This has led experts to study the rise of post-pandemic illnesses. Several factors contribute to this situation. Understanding them is key to...
In a significant move for the local pharmaceutical industry, the South African Health Products Regulatory Authority (SAHPRA) has proposed a new localisation policy to prioritise the registration of locally manufactured products. This policy aims to expedite the...
